Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw

March 23, 2023 updated by: Forian Wenzel-Schwarz, Orthopedic Hospital Vienna Speising

Medial Displacement Calcaneal Osteotomy and FDL- Transfer - a Prospective Comparative Study Between Metal/Bio-Tenodesis Screw (Arthrex) and the Human, Allogeneic Cortical Bone Screw (Shark Screw®️, Surgebright-GmbH)

The goal of this observational study is to compare the use of a screw made of human bone (Shark-Screw®, Surgebright-GmbH) with the metal/Bio-Tenodesis screw (Arthrex) in the treatment of the symptomatic flatfoot using the medializing calcaneus osteotomy with flexor digitorum longus transfer (FDL) in adult patients. The advantage of the human bone screw is that after surgery no hardware removal is necessary. The screw is transformed from the body to normal bone.

The main questions it aims to answer are:

  • Can the human bone screw achieve union rates like the metal/Bio-Tenodesis screw?
  • Is the time to union similar between the different screws?
  • Is the complication rate similar between the different screws?
  • Are the activity scores American Orthopaedic Foot and Ankle Society (AOFAS), Foot and Ankle Outcome Score (FAOS) and Foot Function Index (FFI) after surgery similar in the compared patient groups?

Participants will have

  • the surgery
  • follow-ups at 6 weeks, 6 months, 1 and 2 years.
  • X-rays are performed at each follow up.
  • CT-scans are performed after 6 months.
  • activity scores are collected at the follow up after 6 months, 1 year and 2 years.

Study Overview

Detailed Description

Symptomatic flatfoot deformity in adults often occurs as a result of dysfunction of the Tibialis posterior tendon (TPTD), with a prevalence of 3.3%. Structured non-surgical treatment programs with orthotics and physiotherapy can achieve a high level of long-term subjective and functional satisfaction, with surgery being avoided in 70-89% of cases. Surgical intervention is indicated for progressive or uncontrolled symptoms. Flexible flatfoot deformity, stage II classified by Johnson and Strom, can be treated with a joint-preserving strategy, which usually includes a medializing calcaneal osteotomy, debridement of the tibialis posterior tendon, and transfer of the flexor digitorum longus (FDL) tendon. 87% satisfaction after ten years was observed in both pain relief and foot function and alignment.

Metal screws have been used for decades to treat bone fractures. The removal is the major disadvantage of conventional osteosyntheses and requires a second operation, with all the resulting risks of complications for each patient. The use of the bone screw from allogeneic cortical bone would reduce costs substantially, with a significant reduction in the average complication rate to 0.3%.

The idea of stabilizing fractures using compact bone instead of metal is not new. Obwegeser published the clinical use of 796 screw implants of allogeneic bone and reported that the only complication was the fracture of 6 screws (<1%) and three screw loosening (<0,5%).

Since 2016, the human, allogeneic cortical bone screw(Shark Screw®) has been used by two tissue banks, the Austrian Austrian tissue bank Surgebright-GmbH and the German Institute for Cell and Tissue Replacement (DIZG). The Shark Screw® graft was approved by the competent Austrian authority (AGES) in 2016. The bone graft immediately creates a solid, purely bony connection. This leads to bone remodeling, bone incorporation and optimal reparation in the surgical area. Depending on the loads and requirements, the bone connection adapts for the future. The bone grafts undergo a certified sterilization procedure at the DIZG, which was developed in 1985 at the Berlin Charité.

Due to the lack of further systematic investigations to objectively confirm the theoretically given and subjectively experienced product advantages, this observational study is now being conducted.

The aim of the present study is to evaluate the application of the human allogeneic cortical bone screw (Shark Screw®) and the metal/Bio-Tenodesis screw in the surgical treatment (medializing calcaneus osteotomy with FDL transfer) of symptomatic flatfoot and to systematically document corresponding clinical and radiological parameters before and after surgery.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Vienna, Austria, 1130
        • Recruiting
        • Abteilung für Kinderorthopädie und Fußchirurgie Orthopädisches Spital Speising
        • Contact:
        • Principal Investigator:
          • Florian Wenzel-Schwarz, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

adult patients with an indication for the use of a metal/Bio-Tenodesis screw or human bone screw in medializing calcaneus osteotomy with/without FDL transfer.

The patient has the choice of the treatment method after explanation advantages and disadvantages for each surgery method

Description

Inclusion Criteria

  • Indication for the use of a metal/Bio-Tenodesis screw or human bone screw in medializing calcaneus osteotomy with FDL transfer.
  • BMI< 40 kg/m²

Exclusion Criteria:

  • Insufficient knowledge of German
  • Alcohol and drug abuse
  • Pregnant woman or nursing mother
  • Foreseeable compliance problems
  • Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
  • Active osteomyelitis
  • History of foot surgery
  • Advanced osteoarthritis of the lower ankle joint
  • Ulcerations in the skin of the surgical area
  • Immunosuppressive medications that cannot be discontinued
  • BMI >40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
metal/Bio-Tenodesis group

medializing calcaneal osteotomy, debridement of the tibialis posterior tendon, and/or transfer of the flexor digitorum longus (FDL) tendon with the following screws:

Metal-/Bio-Tenodesis screw (Arthrex, Naples, Florida, USA)

Metal-Screw:

ø 6,7 mm length: 40-60 mm

Bio-Tenodesis screw:

ø 4,00 mm, length: 10 mm ø 4,75 mm, length: 15 mm ø 5,50 mm, length: 15 mm

The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by~10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Metal/Bio-Tenodesis screw(MBS). The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a "shuttle suture". Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with an MBS in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.
Other Names:
  • Metal/Bio-Tenodesis screw intervention
human, allogeneic cortical bone screw (Shark Screw®)

medializing calcaneal osteotomy, debridement of the tibialis posterior tendon, and/or transfer of the flexor digitorum longus (FDL) tendon with the following screws:

Shark Screw® (Surgebright-GmbH, 4040 Lichtenberg, Austria)

Versions used:

Shark Screw® diver ø: 5,0 mm, length: 35 mm Shark Screw® diver ø: 5,0 mm, length: 45 mm Shark Screw® tendon ø: 5,0 mm, length: 15 mm

The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by approx.10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Shark Screw®. The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a "shuttle suture". Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with the Shark Screw® in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.
Other Names:
  • Shark Screw® intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
x-ray qualitative evaluation of changes in bony union of calcaneus osteotomy
Time Frame: 6 weeks, 6 months, 1 year, 2 years
bony union will be evaluated
6 weeks, 6 months, 1 year, 2 years
CT-scan qualitative evaluation of changes in bony union of calcaneus osteotomy
Time Frame: 6 months, 1 year
bony union will be evaluated
6 months, 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in FFI score in comparison to presurgery
Time Frame: 6 months, 1 year and 2 years
Foot Function Index units in percent (%), the higher the better
6 months, 1 year and 2 years
changes in Vas-Pain score in comparison to presurgery
Time Frame: 6 weeks, 6 months, 1 year and 2 years
Visual Analog Scale Pain Score values between 0 and 10, 0= no pain, 10 sever pain
6 weeks, 6 months, 1 year and 2 years
complications
Time Frame: during surgery, 6 weeks, 6 months, 1 year and 2 years
Complications will be recorded during surgery and the kind of complication described, number of patients with complications are given
during surgery, 6 weeks, 6 months, 1 year and 2 years
reoperations
Time Frame: during surgery, 6 weeks, 6 months, 1 year and 2 years
Reoperations will be recorded when needed and the kind of re-operation and number of patients with reoperations are given
during surgery, 6 weeks, 6 months, 1 year and 2 years
pseudoarthrosis
Time Frame: during surgery, 6 months, 1 year and 2 years
Pseudarthrosis will be recorded at the follow up at 2 years and number of patients with Pseudarthrosis are given
during surgery, 6 months, 1 year and 2 years
changes in AOFAS score in comparison to presurgery
Time Frame: 6 months, 1 year and 2 years
The American Orthopedic Foot and Ankle Score (AOFAS) units in percent (%), the higher the better
6 months, 1 year and 2 years
changes in Foot and Ankle Outcome Score (FOAS) score in comparison to presurgery
Time Frame: 6 months, 1 year and 2 years
Foot and Ankle Outcome Score units in percent (%), the higher the better
6 months, 1 year and 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Florian Wenzel-Schwarz, MD, Abteilung für Kinderorthopädie und Fußchirurgie Orthopädisches Spital Speising, Vienna, Austria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2022

Primary Completion (Anticipated)

February 1, 2027

Study Completion (Anticipated)

February 1, 2028

Study Registration Dates

First Submitted

October 21, 2022

First Submitted That Met QC Criteria

December 1, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Actual)

March 27, 2023

Last Update Submitted That Met QC Criteria

March 23, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

due to the sensibility of the row data individual data will only be available on request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deformity, Foot

3
Subscribe